Načítá se...
The Ergogenic Effect of Recombinant Human Erythropoietin on V̇O(2)max Depends on the Severity of Arterial Hypoxemia
Treatment with recombinant human erythropoietin (rhEpo) induces a rise in blood oxygen-carrying capacity (CaO(2)) that unequivocally enhances maximal oxygen uptake (V̇O(2)max) during exercise in normoxia, but not when exercise is carried out in severe acute hypoxia. This implies that there should be...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2500186/ https://ncbi.nlm.nih.gov/pubmed/18714372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0002996 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|